Prosecution Insights
Last updated: May 29, 2026

Examiner: EIX, EMILY FAY

Tech Center 1700 • Art Units: 1653 1796

This examiner grants 52% of resolved cases

Performance Statistics

52.2%
Allow Rate
-12.8% vs TC avg
86
Total Applications
+64.7%
Interview Lift
1180
Avg Prosecution Days
Based on 23 resolved cases, 2023–2026

Rejection Statute Breakdown

0.6%
§101 Eligibility
13.5%
§102 Novelty
58.3%
§103 Obviousness
4.3%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
18026860 METHOD FOR RECOVERING A PROTEIN FROM A FERMENTATION BROTH COMPRISING A HIGH DEGREE OF LYSED CELLS Final Rejection BASF SE
17750123 METHODS FOR ASSESSING TOXICITY OF A COMPOUND Non-Final OA The Chinese University of Hong Kong
17915405 CELL CAPSULATING LAYER, CAPSULATED CELLS, CELL CAPSULATING COMPOSITION AND PREPARATION METHOD THEREFOR Non-Final OA SEOUL NATIONAL UNIVERSITY R&DB FOUNDATION
18259153 ENZYMATIC RECYCLING OF POLYURETHANES BY A COMBINATION OF CUTINASES AND ESTERASES Non-Final OA SOCIETE DES PRODUITS NESTLE S.A.
18037787 BUFFERS AND METHODS FOR PURIFYING PROTEINS Non-Final OA ARES TRADING S.A.
17431813 BEE GUT MICROBIAL FORMULATION FOR USE AS A PROBIOTIC FOR IMPROVED BEE HEALTH AND PATHOGEN RESISTANCE Non-Final OA Board of Regents, The University of Texas System
17947596 L-GLUTAMATE OXIDASE MUTANT Final Rejection AJINOMOTO CO., INC.
18261806 PRODUCTION OF OLIGOSACCHARIDES COMPRISING LN3 AS CORE STRUCTURE IN HOST CELLS Non-Final OA INBIOSE N.V.
18041137 CELLULAR PRODUCTION OF SIALYLATED DI AND/OR OLIGOSACCHARIDES Final Rejection INBIOSE N.V.
18041022 PRODUCTION OF FUCOSYLATED LACTOSE STRUCTURES BY A CELL Final Rejection INBIOSE N.V.
18012296 IMPROVED CYSTEINE-PRODUCING STRAINS Non-Final OA WACKER CHEMIE AG
17746130 THERMAL SWITCH SYSTEM AND APPLICATION THEREOF IN IMPROVING YIELD OF AMINO ACID Non-Final OA Jiangnan University
18007690 KIT AND METHOD Final Rejection DENKA COMPANY LIMITED
18000171 BACTERIAL STRAIN BELONGING TO BACILLUS GENUS, AND MICROBIOLOGICAL CONTROL AGENT USING SAID BACTERIAL STRAIN Final Rejection Kumiai Chemical Industry Co., Ltd.
18267958 Microbial Cells Possessing a Reduced Lactose Internalization For Producing an Oligosaccharide Non-Final OA Chr. Hansen A/S
18277434 ADAMTS13 VARIANT Non-Final OA The University of Manchester
18288797 Pharmaceutical Composition for Improving and Treating Leukotrichia and/or Alopecia and Preparation Method Thereof Non-Final OA Beijing University of Chemical Technology
18025056 CORYNEBACTERIUM GLUTAMICUM VARIANT HAVING ENHANCED L-CITRULLINE PRODUCTION CAPACITY, AND METHOD FOR PRODUCING L-CITRULLINE USING SAME Final Rejection DAESANG CORPORATION
17780819 METHODS AND COMPOSITIONS FOR CULTURING HEMOGLOBIN-DEPENDENT BACTERIA Final Rejection Evelo Biosciences, Inc.
18547979 MODIFIED NEUROTOXIN SINGLE-CHAIN POLYPEPTIDE AND USE THEREOF Non-Final OA CHONGQING CLARUVIS PHARMACEUTICAL CO., LTD.
18452767 METHOD FOR INCREASING CALCIUM ABSORPTION USING CULTURE OF BIFIDOBACTERIUM LONGUM SUBSP. INFANTIS BLI-02 Non-Final OA GLAC BIOTECH CO., LTD.
18263894 MICROBIAL PRODUCTION OF TYROSOL AND SALIDROSIDE Non-Final OA SILICOLIFE LDA.
18329833 BLOOD COAGULATION TEST REAGENT, AND BLOOD COAGULATION TEST METHOD Non-Final OA Thrombo Translational Research Lab Inc.
18036813 BINDING PROTEINS FOR COMPLEMENT FACTOR H (CFH) Non-Final OA Navigo Proteins GmbH
18035143 PRODUCTION AND USE OF A FREEZE-DRIED OR READY-FOR-LYOPHILIZATION HUMAN RNASE INHIBITOR Non-Final OA BLIRT S.A.
18029224 ENGINEERED STABLE LACTATE OXIDOREDUCTASES, COMPOSITIONS, DEVICES, KITS AND USES THEREOF Non-Final OA National University Corporation Tokyo University of Agriculture and Technology
18027030 METHOD FOR PRODUCING A STABLE FRUCTOOLIGOSACCHARIDE COMPOSITION, FRUCTOOLIGOSACCHARIDE COMPOSITION, AND USE THEREOF Non-Final OA BENEO-ORAFTI SA
17141494 Methods of Screening for Microorganisms that Impart Beneficial Properties to Plants Final Rejection BIOCONSORTIA, INC.
18064390 Heterotrophic production of essential long-chain polyunsaturated lipids (LCPUFA) in Auxenochlorella protothecoides Final Rejection PHYCOIL BIOTECHNOLOGY INTERNATIONAL, INC.
17558767 METHOD FOR PREPARING TARGET POLYPEPTIDE BY MEANS OF RECOMBINATION AND SERIES CONNECTION OF FUSED PROTEINS Non-Final OA PEG-BIO BIOPHARM CO., LTD. (CHONGQING)

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month